Get started
Work

Supplementary Table S5 from Development of a Novel CLDN18.2-directed Monoclonal Antibody and Antibody–Drug Conjugate for Treatment of CLDN18.2-Positive Cancers

Year: 2023
Type: supplementary-materials
Abstract: Mean Tumor volumes and mouse body weights from cell line xenograft studies treated with CLDN18.2-207-ADC (Figure 5B)
DOI: 10.1158/1535-7163.24709927.v1
Authors: Neil A. O'Brien, Martina S.J. McDermott, Jun Zhang, Ke Wei Gong, Ming Lu, Benjamin Hoffstrom, Tong Luo, Raul Ayala, Kevin Chau, Min Liang, Athena M. Madrid, Timothy R. Donahue, John A. Glaspy, Leonard Presta, Dennis J. Slamon
Language: English
Field: Medicine
Open Access status: gold
OpenAlex ID: W4389239688
Cites:
Cited by:
Related to: 10